“Real-World Treatment Outcomes and Safety Profiles of Tyrosine Kinase Inhibitors in Iraqi Patients with Chronic Myeloid Leukemia” (2025) Medical Forum Monthly, 36(8). doi:10.60110/medforum.360807.